SOURCE: IBC Life Sciences

June 22, 2005 08:38 ET

Event Helps Companies Keep Pace With Growing Medical Devices Market

Small and Mid-Size Biotechnology Companies to Gather and Discuss Strategic Opportunities

WESTBOROUGH, MA -- (MARKET WIRE) -- June 22, 2005 -- The medical device industry and related technologies account for sales of more than $175 billion worldwide. There are a reported 90,000 approved medical devices on the market today, and more than 180,000 U.S. companies involved in developing, testing, marketing, packaging, and distributing these devices for clinical use.

IBC's conference on Medical Devices: Strategies to Help Smaller and Mid-Size Companies Develop and Maintain a Competitive Edge is designed to help shape business, operational, regulatory, and reimbursement strategies to maximize efficiency, productivity, and output. The conference is set for September 19-20, 2005 at the Hilton Minneapolis/St. Paul Hotel in Bloomington, Minnesota. Industry leaders will gather to discuss sensitive issues including:

--  Learning how to develop a reimbursement strategy and use existing
    guidelines to help capture lost revenue
--  Exploring tools to help customize a regulatory strategy that makes
--  Examining how adaptive trial design can save time and money in running
    clinical trials
--  Discussion on the importance of designing a sound subject recruitment
    process to enhance trial timelines
The Medical Devices event is co-located IBC's Drug/Device Combination Products conference to help attendees network with colleagues and gain an edge in this increasingly competitive and dynamic market. A special keynote address from Jonathan Kahan, Esq., partner at Hogan and Hartson, on "New Development and Strategies for Device and Combination Product Clearances and Approvals" will address the combined conference audience.

To receive a press pass to attend this event, contact Andrew White directly at (508) 614-1227.

About IBC Life Sciences

IBC Life Sciences is an independent organizer that is in business to provide an unbiased forum for the evaluation of current research, market trends, technological developments and applications. IBC Life Sciences is part of IBC USA Conferences, Inc., a division of T&F Informa plc (London: TFI). T&F Informa was created through the merger of Informa Group plc and Taylor & Francis Group plc in May 2004. The two companies are market leaders in providing specialist information to commercial and academic markets through conferences and trade events, as well as the publication of academic, scientific and professional books, journals and newsletters. IBC USA Conferences is headquartered in Westborough, Massachusetts.

To review the complete agenda, visit:

Contact Information

  • Contact:
    Andrew White
    IBC Life Sciences
    (508) 616-5550 Ext. 227
    Email Contact